SML0053

CP-101,606

≥98% (HPLC)

• 同義詞: Traxoprodil; (1S,2S)-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol; CP-101606
• 經驗公式（希爾表示法）: C₂₀H₂₅NO₃
• CAS號碼: 134234-12-1
• 分子量：: 327.42
• MDL號碼: MFCD00926469
• 分類程式碼代碼: 12352200
• PubChem物質ID: 329825120
• NACRES: NA.77

屬性

• 化驗: ≥98% (HPLC)
• 形狀: powder
• 光學活性: [α]/D +50 to +60° (c=1, MeOH)
• 顏色: white to tan
• 溶解度: DMSO: ≥35 mg/mL
• 儲存溫度: 2-8°C
• SMILES 字串: C[C@@H]([C@@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3
• InChI: 1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1
• InChI 密鑰: QEMSVZNTSXPFJA-HNAYVOBHSA-N
• 基因資訊: human ... GRIN1(2902) , GRIN2B(2904)

描述

一般說明

CP-101,606 (Traxoprodil) is a substituted 4-phenylpiperidine and is localized in the fore brain neurons.[1][2]

應用

CP-101,606 has been used as a N-methyl-D-aspartate (NMDA) receptor antagonist to study its role in recovery of spinal cord injuries.[3]

生化／生理作用

CP-101,606 (Traxoprodil) plays a role in inhibiting glutamate-induced death in rats. It may exhibit therapeutic effects against human ischemia and neurodegenerative disorders.[1] Traxoprodil is metabolized by cytochrome P450 (CYP) 2D6.[2]

Traxoprodil (CP-101,606) is a potent noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors, selective for the NR2B subunit. It has been shown to be neuroprotective in animal models of brain injury and stroke.

Traxoprodil (CP-101,606) is an NR2B selective NMDA antagonist

特點和優勢

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the Glutamate Receptors (Ion Channel Family) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable